Evidence map›Paper›PMID 31705736›Full record

ArticleJournal of diabetes investigation2020

Family history of diabetes in both parents is strongly associated with impaired residual β-cell function in Japanese type 2 diabetes patients.

Minoru Iwata, Yutaka Kamura, Hisae Honoki, Kaori Kobayashi, Manabu Ishiki, Kunimasa Yagi, Yasuo Fukushima, Atsuko Takano, Hiromi Kato, Shihou Murakami and 5 more

Open access · goldAbstract read
In one paragraph

Article in Journal of diabetes investigation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 10 institutions in 1 country.

Minoru IwataFirst Department of Internal Medicine, Faculty of Medicine, University of Toyama, Toyama, Japan.ORCID https://orcid.org/0000-0003-2161-1313
Yutaka KamuraFirst Department of Internal Medicine, Faculty of Medicine, University of Toyama, Toyama, Japan.
Hisae HonokiFirst Department of Internal Medicine, Faculty of Medicine, University of Toyama, Toyama, Japan.
Kaori KobayashiFirst Department of Internal Medicine, Faculty of Medicine, University of Toyama, Toyama, Japan.
Manabu IshikiFirst Department of Internal Medicine, Faculty of Medicine, University of Toyama, Toyama, Japan.
Kunimasa YagiFirst Department of Internal Medicine, Faculty of Medicine, University of Toyama, Toyama, Japan.ORCID https://orcid.org/0000-0002-6805-6428
Yasuo FukushimaDepartment of Internal Medicine, Asahi General Hospital, Asahi-machi, Japan.
Atsuko TakanoDivision of Endocrinology and Metabolism, Department of Internal Medicine, Saiseikai Takaoka Hospital, Takaoka, Japan.
Hiromi KatoDepartment of Internal Medicine, Japan Community Health care Organization Takaoka Fushiki Hospital, Takaoka, Japan.
Shihou MurakamiDivision of Endocrinology and Metabolism, Department of Internal Medicine, Toyama Rosai Hospital, Uozu, Japan.
Kiyohiro HiguchiDepartment of Internal Medicine, JA Niigata Kouseiren Itoigawa General Hospital, Itoigawa, Japan.
Chikaaki KobashiDepartment of Internal Medicine, Kamiichi General Hospital, Kamiichi-machi, Japan.
Kazuhito FukudaDepartment of Internal Medicine, Fukuda Clinic, Himi, Japan.
Yukiko KoshimizuDepartment of Internal Medicine, Urata Clinic, Kanazawa, Japan.
Kazuyuki TobeFirst Department of Internal Medicine, Faculty of Medicine, University of Toyama, Toyama, Japan.ORCID https://orcid.org/0000-0003-0015-0255
University of Toyama · JPToyama University Hospital · JPAsahi General Hospital · JPFukuda Denshi (Japan) · JPJapan Community Healthcare Organization · JPKamiichi General Hospital · JPKanazawa Hospital · JPMiwa Hospital · JPSaiseikai Takaoka Hospital · JPToyama Rosai Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

AIMS/

introductionThe objective of the present study was to clarify the association of the type and number of first-degree family history of diabetes (FHD) with the clinical characteristics, especially with residual β-cell function, in type 2 diabetes patients. MATERIALS AND

methodsA total of 1,131 type 2 diabetes patients were recruited and divided into four groups according to FHD information as follows: (i) patients without FHD (FHD-); (ii) those with at least one sibling who had diabetes without parental diabetes (FHD+); (iii) those with one parent (FHD++); or (iv) those with both parents (FHD+++) who had diabetes with or without a sibling with diabetes.

resultsThe percentages of the FHD-, FHD+, FHD++ and FHD+++ groups were 49.4%, 13.4%, 34.0% and 3.2%, respectively. Patients in the FHD++ and FHD+++ groups were significantly younger at the time of diabetes diagnosis (P < 0.001) than those in the FHD- and FHD+ groups, even after adjusting for confounding factors. In addition, the levels of insulin secretion were significantly lower in the patients in the FHD+, FHD++ and FHD+++ groups than those in the FHD- group (P < 0.05) after adjusting for confounding factors, and the patients in the FHD+++ group presented with the lowest levels of insulin secretion among the four groups.

conclusionsOur results showed that in type 2 diabetes patients, the degree of the associations between FHD and clinical characteristics differs according to the number and the type of FHD. In particular, FHD in both parents is most strongly associated with impaired residual β-cell function.

Indexed as

AgedCohort StudiesDiabetes ComplicationsDiabetes Mellitus, Type 2FemaleHumansInsulin-Secreting CellsJapanMaleMedical History TakingMiddle AgedParentsRisk FactorsFamily history of diabetesType 2 diabetesβ-Cell function

Identifiers

PMID31705736
PMCPMC7232274
OpenAlexW2987692546

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.